RI-1
Names
Preferred IUPAC name
3-Chloro-1-(3,4-dichlorophenyl)-4-(morpholin-4-yl)-1H-pyrrole-2,5-dione
Identifiers
3D model (JSmol)
UNII
  • C1COCCN1C2=C(C(=O)N(C2=O)C3=CC(=C(C=C3)Cl)Cl)Cl
Properties
C14H11Cl3N2O3
Molar mass 361.60 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

RI-1 is a selective inhibitor of RAD51, which is a central gene molecule of homologous recombination, with IC50 ranging from 5 to 30 μM.[1]

Antitumor mechanism

RAD51 is a eukaryote gene, encoding RAD51 protein that participates in DNA damage induction and complex signal pathway of cell cycle checkpoint of homologous recombination in cells. However, over-expression of RAD51 may lead the occurrence and development progress of tumours and besides, the insensitivity of tumours to chemoradiotherapy. At present, over-expression of RAD51 has been found in many kinds of human cancers, such as breast cancer, lung cancer and ovarian cancer.

RI-1 inhibits the over-expression of RAD51 in cancer cells by bonding covalently to the surface of RAD51 protein at Cys 319 and irreversibly loosen a protein-protein interface that is essential for filament formation and recombinase activity.

Targeted drugs to RAD51 has the prospect to be a new generation of oncologic drugs, like RI-1. It is also a unique tool for mechanism studies of DNA repair.[2]

References

  1. ↑ "Biological activity of RI-1 in vitro". selleck chemicals.
  2. ↑ Budke B, et al. (Aug 2012). "RI-1:a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells". Nucleic Acids Res. 40 (15): 7347–57. doi:10.1093/nar/gks353. PMC 3424541. PMID 22573178.

Literature

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.